Journal
GASTRIC CANCER
Volume 25, Issue 4, Pages 712-725Publisher
SPRINGER
DOI: 10.1007/s10120-022-01293-x
Keywords
Prognosis; Gastric cancer; Peritoneal dissemination; Treatment; Small extracellular vesicles
Categories
Ask authors/readers for more resources
By removing gastric cancer-derived small extracellular vesicles, the proliferative and migrative abilities of gastric cancer cells can be suppressed, reducing their adhesion to peritoneal mesothelial cells. This alteration in gene expression pathways of gastric cancer cells leads to inhibition of gastric cancer cell growth and peritoneal dissemination in vivo, providing insights into a novel therapy for inhibiting peritoneal dissemination of gastric cancer.
Background The prognosis of gastric cancer patients with peritoneal dissemination is extremely poor and effective treatment for peritoneal dissemination has not been established. Gastric cancer-derived small extracellular vesicles play an important role in the development of a favorable microenvironment for peritoneal metastasis and progression of peritoneal dissemination. Here, we aimed to investigate the transformation of gastric cancer cells by removing gastric cancer-derived small extracellular vesicles and to develop a novel therapy for inhibiting peritoneal dissemination. Methods Gastric cancer cells were cultured in medium containing gastric cancer- and peritoneal mesothelium-derived small extracellular vesicles and in medium from which small extracellular vesicles were removed by ultracentrifugation. Cell function assays were performed in vitro, and the alternations in gene expression in gastric cancer cells were analyzed. The inhibitory effect of intraperitoneal lavage on peritoneal dissemination was investigated in vivo as a method to remove gastric cancer-derived small extracellular vesicles. Results Removal of gastric cancer-derived small extracellular vesicles suppressed the proliferative and migrative abilities of gastric cancer cells and the adhesion of gastric cancer cells to peritoneal mesothelial cells. It altered the expression of several genes related to the cell cycle and epithelial-mesenchymal transition pathways of gastric cancer cells, leading to the inhibition of gastric cancer cell growth and peritoneal dissemination in vivo. Conclusions Our study provides novel insights into a novel therapy for inhibiting the peritoneal dissemination of gastric cancer by targeting gastric cancer-derived small extracellular vesicles to improve the prognosis of gastric cancer patients with peritoneal metastasis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available